Lyra Therapeutics Inc Financial Flexibility Index
Lyra Therapeutics Inc financial flexibility index. Lyra Therapeutics Inc (LYRA) has a Financial Flexibility Index of -0.13x as of December 2025. Free cash flow of $-5.97 Million (operating CF $-6.07 Million minus capex $96.00K) represents 0% of total liabilities ($46.83 Million). See Lyra Therapeutics Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Lyra Therapeutics Inc (2018–2025)
Financial flexibility index of Lyra Therapeutics Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Lyra Therapeutics Inc across 8 annual periods. Explore Lyra Therapeutics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Lyra Therapeutics Inc Financial Flexibility Index by Year (2018–2025)
Lyra Therapeutics Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Lyra Therapeutics Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Lyra Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.61x | $-28.74 Million | $-28.86 Million | $46.83 Million | ▲ +50.3% |
| 2024 | -1.24x | $-67.67 Million | $-70.01 Million | $54.75 Million | ▼ -5.6% |
| 2023 | -1.17x | $-62.26 Million | $-63.30 Million | $53.18 Million | ▲ +20.9% |
| 2022 | -1.48x | $-43.22 Million | $-43.38 Million | $29.21 Million | ▼ -35.5% |
| 2021 | -1.09x | $-22.43 Million | $-25.82 Million | $20.55 Million | ▲ +64.3% |
| 2020 | -3.06x | $-19.37 Million | $-21.14 Million | $6.34 Million | ▼ -72.3% |
| 2019 | -1.77x | $-13.54 Million | $-13.75 Million | $7.63 Million | ▼ -3457.6% |
| 2018 | -0.05x | $-6.60 Million | $-6.64 Million | $132.43 Million | — |